You're viewing a public preview of Apeiron Biologics AG - Isqette (Dinutuximab Beta) Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Apeiron Biologics AG - Isqette (Dinutuximab Beta)

Inactive
Langhorne,  Pennsylvania (PA),  19047,  United States
Sector: Life Science Entity: Private
Merged Apeiron Biologics AG - Isqette (Dinutuximab Beta) merged into EUSA Pharma, Inc. in 2016
2
Transactions
Sign up to view
About Apeiron Biologics AG - Isqette (Dinutuximab Beta)
Available information shows that Apeiron Biologics AG - Isqette (Dinutuximab Beta) operates in the Life Science sector. It is active in the Life Science space. The company is headquartered in Langhorne, Pennsylvania (PA).
Investors
Current Investors
EUSA Pharma, Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Apeiron Biologics AG - Isqette (Dinutuximab Beta) M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Apeiron Biologics AG - Isqette (Dinutuximab Beta) do?
Available information shows that Apeiron Biologics AG - Isqette (Dinutuximab Beta) operates in the Life Science sector. It is active in the Life Science space. The company is headquartered in Langhorne, Pennsylvania (PA).
Where is Apeiron Biologics AG - Isqette (Dinutuximab Beta) headquartered?
Apeiron Biologics AG - Isqette (Dinutuximab Beta) is headquartered in Langhorne, Pennsylvania (PA), United States.
When was Apeiron Biologics AG - Isqette (Dinutuximab Beta) founded?
Founded year information for Apeiron Biologics AG - Isqette (Dinutuximab Beta) is available on AcquityData.
What sector is Apeiron Biologics AG - Isqette (Dinutuximab Beta) in?
Apeiron Biologics AG - Isqette (Dinutuximab Beta) operates in the Life Science sector.
Who are the investors in Apeiron Biologics AG - Isqette (Dinutuximab Beta)?
Current investors in Apeiron Biologics AG - Isqette (Dinutuximab Beta) include EUSA Pharma, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Apeiron Biologics AG - Isqette (Dinutuximab Beta) been involved in?
Apeiron Biologics AG - Isqette (Dinutuximab Beta) has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Apeiron Biologics AG - Isqette (Dinutuximab Beta) profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Apeiron Biologics AG - Isqette (Dinutuximab Beta)'s complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial